Celularity Corp (CELU): Total Asset Value of Company
This price chart illustrating the value trends of Celularity Inc. (CELU) total assets, which reach 108.43, showcases a company that has implemented robotic systems for the seamless cultivation of stem cells. The business is currently focusing on scaling the sales of regenerative materials and launching its first clinical trials. The enterprise specializes in developing advanced placental tissue-based therapies to combat oncology and restore the body's defensive functions.
Comprehensive metric breakdowns and analytics for celularity.com (CELU)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:CELU, Celularity Corp
Developing oncology treatments based on placental cells requires significant capital expenditures in technological infrastructure and R&D. A reverse calculation via ROA allows for an assessment of the total volume of resources and liabilities, where the growth dynamics of assets and resources reflect the ability of Celularity Inc. (CELU) to scale biomaterials to achieve FDA certification and ensure long-term market sustainability.
Competitors of Celularity Inc. (CELU)
ARGX (argenx.com) - Company Total Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|SVRA: Company Total Assets|RIGL - Cumulative Company Assets|Company Total Assets ANAB|ATXS (astriatx.com) - Company Assets|Aggregate Company Assets enGene|Aggregate Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets JBIO|Company Total Assets ACRS (Aclaris Therapeutics, Inc)|Aggregate Company Assets Kyverna Therapeutics KYTX|Aggregate Company Assets tizianalifesciences.com TLSA|Cabaletta Bio - Company Total Assets|VTYX: Company Total Assets|Aggregate Company Assets Theratechnologies Inc THTX|Avalo Therapeutics Inc (AVTX) - Aggregate Asset Value|ELDN: Company Total Assets|Company Total Asset Base agenusbio.com (AGEN)|Cumulative Company Assets Climb Bio|Aggregate Business Assets Zura Bio Ltd ZURA|ATYR: Cumulative Company Assets|ADAG - Company Assets|Cumulative Company Assets Ikena Oncology, Inc. (IMA)|STTK - Aggregate Asset Value|equilliumbio.com - Company Total Assets|CNTB (Connect Biopharma Holdings Limited) - Company Total Asset Base|Aggregate Company Assets Immunic Therapeutics (IMUX)|Total Business Assets Atara Biotherapeutics Inc|Company Total Assets IFRX (InflaRx N.V.)|Cumulative Company Assets x4pharma.com XFOR|Cumulative Company Assets ACET|Company Total Asset Base INmune Bio Inc INMB|BRNS: Company Total Assets|KZR - Cumulative Company Assets|Company Total Assets SABS|AKTX (akaritx.com) - Company Assets|Aggregate Company Assets Enlivex Therapeutics Ltd|Aggregate Company Assets Q32 Bio Corp (QTTB)|Cumulative Company Assets GOVX|Company Total Assets EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Aggregate Company Assets|Total Asset Value of Company Carisma Therapeutics Inc CARM|Company Total Assets XTL Biopharmaceuticals Ltd. (XTLB)|BOLT - Aggregate Asset Value|HCWB: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Company Total Assets|AIM - Aggregate Company Assets|Aggregate Asset Value ADTX|Aggregate Company Assets GRI (GRI Bio)|Cumulative Company Assets XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|REVB - Company Total Assets|Cumulative Company Assets Indaptus Therapeutics (INDP)|SCNI - Aggregate Asset Value|calcimedica.com - Company Total Assets|AFMD (Affimed N.V.) - Company Total Asset Base|Aggregate Company Assets ALLK|Cumulative Company Assets HOOK|Aggregate Company Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets iteostherapeutics.com ITOS|Cumulative Company Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc - Company Total Assets|Third Harmonic Bio, Inc (THRD) - Aggregate Company Assets